These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1579 related articles for article (PubMed ID: 34118455)

  • 1. Autoimmunity and COVID-19 - The microbiotal connection.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Aug; 20(8):102865. PubMed ID: 34118455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microbiome links between aging and lupus.
    Katz-Agranov N; Zandman-Goddard G
    Autoimmun Rev; 2021 Mar; 20(3):102765. PubMed ID: 33476814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrointestinal Manifestations of SARS-CoV-2: Transmission, Pathogenesis, Immunomodulation, Microflora Dysbiosis, and Clinical Implications.
    Durairajan SSK; Singh AK; Saravanan UB; Namachivayam M; Radhakrishnan M; Huang JD; Dhodapkar R; Zhang H
    Viruses; 2023 May; 15(6):. PubMed ID: 37376531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role.
    Din AU; Mazhar M; Waseem M; Ahmad W; Bibi A; Hassan A; Ali N; Gang W; Qian G; Ullah R; Shah T; Ullah M; Khan I; Nisar MF; Wu J
    Biomed Pharmacother; 2021 Jan; 133():110947. PubMed ID: 33197765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of COVID-19 on the Intestinal Microbiome.
    Venegas-Borsellino C; Sankararaman S; Roche K; Burns J; Landis RM
    Curr Nutr Rep; 2021 Dec; 10(4):300-306. PubMed ID: 34813042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coronavirus Disease (COVID-19) Caused by (SARS-CoV-2) Infections: A Real Challenge for Human Gut Microbiota.
    Vodnar DC; Mitrea L; Teleky BE; Szabo K; Călinoiu LF; Nemeş SA; Martău GA
    Front Cell Infect Microbiol; 2020; 10():575559. PubMed ID: 33363049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbiota Modulation of the Gut-Lung Axis in COVID-19.
    de Oliveira GLV; Oliveira CNS; Pinzan CF; de Salis LVV; Cardoso CRB
    Front Immunol; 2021; 12():635471. PubMed ID: 33717181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 - gastrointestinal and gut microbiota-related aspects.
    Kaźmierczak-Siedlecka K; Vitale E; Makarewicz W
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10853-10859. PubMed ID: 33155247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 influenced gut dysbiosis, post-acute sequelae, immune regulation, and therapeutic regimens.
    Raj ST; Bruce AW; Anbalagan M; Srinivasan H; Chinnappan S; Rajagopal M; Khanna K; Chandramoorthy HC; Mani RR
    Front Cell Infect Microbiol; 2024; 14():1384939. PubMed ID: 38863829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiological mechanisms underlying gastrointestinal symptoms in patients with COVID-19.
    Jin B; Singh R; Ha SE; Zogg H; Park PJ; Ro S
    World J Gastroenterol; 2021 May; 27(19):2341-2352. PubMed ID: 34040326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxonomical and functional changes in COVID-19 faecal microbiome could be related to SARS-CoV-2 faecal load.
    Grenga L; Pible O; Miotello G; Culotta K; Ruat S; Roncato MA; Gas F; Bellanger L; Claret PG; Dunyach-Remy C; Laureillard D; Sotto A; Lavigne JP; Armengaud J
    Environ Microbiol; 2022 Sep; 24(9):4299-4316. PubMed ID: 35506300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. COVID-19 and the gastrointestinal tract: Source of infection or merely a target of the inflammatory process following SARS-CoV-2 infection?
    Troisi J; Venutolo G; Pujolassos Tanyà M; Delli Carri M; Landolfi A; Fasano A
    World J Gastroenterol; 2021 Apr; 27(14):1406-1418. PubMed ID: 33911464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current Drug Targets for Gut Microbiota Biocorrection during the SARS-CoV-2 Pandemic: A Systematic Review.
    Sankova MV; Nikolenko VN; Oganesyan MV; Bakhmet AA; Gavryushova LV; Sankov SV; Sinelnikov MY
    Curr Drug Targets; 2022; 23(11):1099-1125. PubMed ID: 35440305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment.
    Wang M; Zhang Y; Li C; Chang W; Zhang L
    Front Immunol; 2023; 14():1180336. PubMed ID: 37205106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
    Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
    Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations of the gut microbiota in coronavirus disease 2019 and its therapeutic potential.
    Xiang H; Liu QP
    World J Gastroenterol; 2022 Dec; 28(47):6689-6701. PubMed ID: 36620345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
    Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
    Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 and gut immunomodulation.
    Roy K; Agarwal S; Banerjee R; Paul MK; Purbey PK
    World J Gastroenterol; 2021 Dec; 27(46):7925-7942. PubMed ID: 35046621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 79.